Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Factors for Liver Injury in NPC with Docetaxel and Cisplatin
NCT03069820Phase 4Unknown
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Feb 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of docetaxel, cisplatin in nasopharyngeal carcinoma (NPC), sponsored by The Second Affiliated Hospital of Nanchang University. Status: unknown.
02
Drugs
docetaxelcisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03069820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069820.